MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome

Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2

(2016) Xin-Zheng Wang et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

The PDCD4/miR-21 pathway in medullary thyroid carcinoma

(2015) Gianmaria Pennelli et al.   HUMAN PATHOLOGY

Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

(2015) Samuel A. Wells et al.   THYROID

Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy

(2013) H V Reddi et al.   CANCER GENE THERAPY

A miRNA signature associated with human metastatic medullary thyroid carcinoma

(2013) Libero Santarpia et al.   ENDOCRINE-RELATED CANCER

Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma

(2013) Jena Hudson et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

(2012) Marilena V. Iorio et al.   EMBO Molecular Medicine

MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome

(2012) Caterina Mian et al.   THYROID

miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer

(2011) E. Nishikawa et al.   CANCER RESEARCH

MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets

(2011) D. Abraham et al.   CLINICAL CANCER RESEARCH

Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification

(2011) Caterina Mian et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

High Prevalence ofRASMutations inRET-Negative Sporadic Medullary Thyroid Carcinomas

(2011) Margarida M. Moura et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma

(2011) M. R. Tanas et al.   Science Translational Medicine

BRAFK601E Mutation in a Patient with a Follicular Thyroid Carcinoma

(2011) Gianmaria Pennelli et al.   THYROID

miR-146b is Highly Expressed in Adult Papillary Thyroid Carcinomas with High Risk Features Including Extrathyroidal Invasion and the BRAFV600E Mutation

(2010) Chen-Kai Chou et al.   THYROID

Targeting the RET Pathway in Thyroid Cancer

(2009) S. A. Wells et al.   CLINICAL CANCER RESEARCH

MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype

(2009) Libero Santarpia et al.   ENDOCRINE-RELATED CANCER

Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas

(2009) Pierlorenzo Pallante et al.   ENDOCRINE-RELATED CANCER

Causes and consequences of microRNA dysregulation in cancer

(2009) Carlo M. Croce   NATURE REVIEWS GENETICS

Bronchopulmonary Carcinoid: Phenotype and Long-term Outcome in a Single-Institution Series of Italian Patients

(2008) M. Rugge et al.   CLINICAL CANCER RESEARCH

Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times

(2008) Anne Laure Giraudet et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility

(2008) Marina N. Nikiforova et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM